Cause of death, by non-communicable diseases, ages 60+, female in Low & middle income
Low & middle income: Cause of death, by non-communicable diseases, ages 60+, female was 73.6% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 60+, female in Low & middle income, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 60+.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 60+, female in Low & middle income is 73.6%, measured in 2021. That is the lowest value across all 6 years on record.
That represents a change of down 8.6% on the previous year and down 12.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, female in Low & middle income peaked at 86.3% in 2019 and was at its lowest, 73.6%, in 2021.
That places Low & middle income 24th out of 47 groups with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 60+, female in Low & middle income, year by year
| Year | % of total female deaths ages 60+ | Change |
|---|---|---|
| 2000 | 81.6% | — |
| 2010 | 84.5% | +3.5% |
| 2015 | 85.4% | +1.1% |
| 2019 | 86.3% | +1.0% |
| 2020 | 80.6% | -6.6% |
| 2021 | 73.6% | -8.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 81.6% | 81.6% | 81.6% | 1 |
| 2010s | 85.4% | 84.5% | 86.3% | 3 |
| 2020s | 77.1% | 73.6% | 80.6% | 2 |
Countries ranked near Low & middle income
More health data for Low & middle income
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 1.41 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0331 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, annual growth rate -0.9493 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 2.33 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0323 units per person (2025)
- Population ages 35-39, female, per capita 0.036 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, female in Low & middle income?
- Cause of death, by non-communicable diseases, ages 60+, female in Low & middle income was 73.6% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, female recorded in Low & middle income?
- The highest recorded value was 86.3% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, female recorded in Low & middle income?
- The lowest recorded value was 73.6% in 2021.
- How does Low & middle income rank for cause of death, by non-communicable diseases, ages 60+, female?
- Low & middle income ranks 24th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, female rising or falling in Low & middle income?
- Over the last ten years it is down 12.9%. The long-run trend across the full record is flat.
- Where does this Low & middle income data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.